| Literature DB >> 31477018 |
Chhaya Shah1, Ratna Baral1, Bijay Bartaula2, Lok Bahadur Shrestha3.
Abstract
BACKGROUND: Escherichia coli has found to be the predominant uropathogen (50-90%) in uncomplicated, community acquired urinary tract infection (UTI). Uropathogenic Escherichia coli (UPEC) express a multitude of virulence factors, which enable the bacteria to establish UTI. The objective of this study was to evaluate the presence of different phenotypic virulence markers in UPEC isolates and determine their correlation with antibiotic resistance pattern.Entities:
Keywords: Hemagglutinin; Hemolysin; MDR; UPEC; Virulence factor
Mesh:
Substances:
Year: 2019 PMID: 31477018 PMCID: PMC6720075 DOI: 10.1186/s12866-019-1587-3
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Virulence marker of UPEC and control
| Virulence markers | UPEC (105) | Control (105) | P value | Remarks | |
|---|---|---|---|---|---|
| 1 | Hemolysin production | 34 (32.3%) | 12 (11.4%) | P = 0.002 | Significant |
| 2. | Biofilm production | 65 (62%) | 1 (1%) | P = 0.0001 | Significant |
| 3. | Hemagglutinin | P < 0.0001 | Significant | ||
| MRHA | 55 (52.3%) | 9 (8.5%) | |||
| MSHA | 6 (5.7%) | 0 (0%) | |||
| 4. | Gelatinase | 0 | 0 | NA |
NA: Not applicable
Comparison of antibiotic resistance (%) between UPEC and commensal isolates
| Antibiotic | UPEC (n = 105) | Commensals (n = 105) | P value |
|---|---|---|---|
| Amikacin | 22 | 10 | 0.01 |
| Ampicillin | 51 | 30 | 0.002 |
| Ceftriaxone | 40 | 20 | 0.0016 |
| Cotrimoxazole | 46 | 15 | 0.0001 |
| Meropenem | 20 | 2 | 0.0001 |
| Nitrofurantoin | 28 | 12 | 0.0038 |
| Norfloxacin | 43 | 15 | 0.0001 |
Relationship between antimicrobial resistance and virulence factor genes in UPEC
| Antibiotic resistance (%) | |||||||
|---|---|---|---|---|---|---|---|
| Virulence marker | Amikacin | Ampicillin | Ceftriaxone | Cotrimoxazole | Meropenem | Nitrofurantoin | Norfloxacin |
| Hemolysin | |||||||
| Positive (n = 34) | 41 | 88 | 73 | 85 | 35 | 50 | 70 |
| Negative (n = 71) | 12 | 33 | 25 | 28 | 12 | 18 | 30 |
| P value | 0.001 | 0.0001 | 0.0001 | 0.0001 | 0.007 | 0.001 | 0.003 |
| Biofilm | |||||||
| Positive (n = 65) | 30 | 67 | 49 | 60 | 26 | 38 | 52 |
| Negative (n = 40) | 7.5 | 25 | 27 | 25 | 10 | 12.5 | 30 |
| P value | 0.005 | 0.0001 | 0.028 | 0.375 | 0.044 | 0.04 | 0.041 |
| Hemagglutinin | |||||||
| MRHA positive (n = 55) | 32 | 69 | 52 | 67 | 23 | 36 | 58 |
| MRHA negative (n = 50) | 10 | 32 | 28 | 24 | 16 | 20 | 28 |
| P value | 0.005 | 0.001 | 0.01 | 0.126 | 0.329 | 0.064 | 0.012 |
| MSHA positive (n = 6) | 66 | 83 | 83 | 83 | 50 | 83 | 83 |
| MSHA negative (n = 99) | 19 | 49 | 38 | 44 | 18 | 25 | 41 |
| P value | 0.006 | 0.088 | 0.030 | 0.001 | 0.05 | 0.002 | 0.179 |
Comparison of MDR and ESBL between test and control, virulence positive and negative UPEC
| UPEC (n = 105) | Commensal (n = 105) | P value | Virulence Positive UPEC (n = 69) | Virulence negative UPEC (n = 36) | P value | |
|---|---|---|---|---|---|---|
| MDR | 51% (n = 54) | 9% (n = 10) | 0.0001 | 69% (n = 48) | 16% (n = 6) | 0.0001 |
| ESBL | 46% (n = 49) | 7.6% (n = 8) | 0.0001 | 63% (n = 44) | 13% (n = 5) | 0.0001 |